Research presented at SfN has provided insight into the neural risks and benefits of marijuana use, including development and Alzheimer’s disease.
Browsing: Development and pediatrics
Three studies have been highlighted at SfN Neuroscience on the links between adolescent brain development, mental health and substance abuse.
Gene therapy for disorders such as amyotrophic lateral sclerosis, Parkinson’s disease and Batten disease has seen success in animal models.
For the first time in the UK, a team of surgeons have operated on abnormally developed spinal cords of two fetuses with spina bifida.
Scientists at The Wellcome Sanger Institute have determined that the risk of suffering from a range of monogenic neurodevelopmental genetic disorders can be affected by common genetic variations.
Whilst at FENS 2018, we spoke with Arnold Kriegstein on his work with cerebral organoids in brain development, and how we might define a cell’s maturity.
A novel study has revealed that elevated pesticide levels in pregnant women are associated with an increased risk of autism among their children.
NICE have issued a draft guidance against the use of Spinraza® (nusinersen) as an NHS treatment for spinal muscular atrophy.
Research presented at AAIC has highlighted sex differences associated with dementia and Alzheimer’s disease across the life course, including the first ever large-scale study of reproductive history and dementia risk in women.
Researchers have demonstrated that a pregnant mother’s gut health may be linked to the risk of autism development in their offspring; this may lead to a new understanding of how to prevent neurodevelopmental disorders.